MicroRNA-125b is involved in atherosclerosis obliterans in vitro by targeting podocalyxin

Li,Xiaobing; Yao,Na; Zhang,Juan; Liu,Zhenjiang

doi:10.3892/mmr.2015.3384

MicroRNA-125b is involved in atherosclerosis obliterans in vitro by targeting podocalyxin

Authors:
- Xiaobing Li
- Na Yao
- Juan Zhang
- Zhenjiang Liu
View Affiliations

Affiliations: Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China
Published online on: February 24, 2015 https://doi.org/10.3892/mmr.2015.3384
Pages: 561-568

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cardiovascular disease associated with oxidative stress, including atherosclerosis, is the leading cause of mortality worldwide. The accelerated proliferation and migration of vascular smooth muscle cells are the predominant characteristics of atherogenesis, and endothelial dysfunction is a major risk factor for the pathogenesis of atherosclerosis. Podocalyxin (PODXL), a type I member of the cluster of differentiation 34 family of sialomucins, functions as a pro‑adhesive molecule. Emerging evidence has revealed the importance of micro (mi)RNAs in the cardiovascular system. The present study demonstrated that there was an inverse association between miRNA (miR)‑125b and PODXL in human umbilical vein endothelial cells and human aortic vascular smooth muscle cells (HAVSMCs) treated with oxidized low‑density lipoprotein (LDL) and platelet derived growth factor. Additionally, miR‑125b had a suppressive function in cell proliferation and migration, at least partially via targeting PODXL in the HAVSMCs. Furthermore, the data suggested that the functions of miR‑125b in arteriosclerosis obliterans may be associated with transgelin, lectin‑type oxidized LDL receptor‑1, vascular endothelial‑cadherin, intercellular adhesion molecule‑1, interleukin‑6 and monocyte chemotactic protein‑1. In conclusion, miR‑125b was found to be important in arteriosclerosis obliterans by suppressing the expression of PODXL and may serve as a potential therepeutic target for the treatment of arteriosclerosis obliterans.

View Figures

View References

1	Di Pietro M, Filardo S, De Santis F, Mastromarino P and Sessa R: Chlamydia pneumoniae and oxidative stress in cardiovascular disease: State of the art and prevention strategies. Int J Mol Sci. 16:724–735. 2014. View Article : Google Scholar
2	Endemann DH and Schiffrin EL: Endothelial dysfunction. J Am Soc Nephrol. 15:1983–1992. 2004. View Article : Google Scholar : PubMed/NCBI
3	Guo J, Li L, Wu YJ, et al: Inhibitory effects of Brazilin on the vascular smooth muscle cell proliferation and migration induced by PDGF-BB. Am J Chin Med. 41:1283–1296. 2013. View Article : Google Scholar : PubMed/NCBI
4	Michael AF, Blau E and Vernier RL: Glomerular polyanion. Alteration in aminonucleoside nephrosis. Lab Invest. 23:649–657. 1970.PubMed/NCBI
5	Hara M, Yanagihara T, Takada T, et al: Podocalyxin on the glomerular epithelial cells is preserved well in various glomerular diseases. Nephron. 67:123–124. 1994. View Article : Google Scholar : PubMed/NCBI
6	Somasiri A, Nielsen JS, Makretsov N, et al: Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression. Cancer Res. 64:5068–5073. 2004. View Article : Google Scholar : PubMed/NCBI
7	Larrucea S, Butta N, Rodriguez RB, et al: Podocalyxin enhances the adherence of cells to platelets. Cell Mol Life Sci. 64:2965–2974. 2007. View Article : Google Scholar : PubMed/NCBI
8	Cipollone JA, Graves ML, Köbel M, et al: The anti-adhesive mucin podocalyxin may help initiate the transperitoneal metastasis of high grade serous ovarian carcinoma. Clin Exp Metastasis. 29:239–252. 2012. View Article : Google Scholar : PubMed/NCBI
9	Fernández D, Horrillo A, Alquezar C, González-Manchón C, Parrilla R and Ayuso MS: Control of cell adhesion and migration by podocalyxin. Implication of Rac1 and Cdc42. Biochem Biophys Res Commun. 432:302–307. 2013. View Article : Google Scholar : PubMed/NCBI
10	Lin CW, Sun MS and Wu HC: Podocalyxin-like 1 is associated with tumor aggressiveness and metastatic gene expression in human oral squamous cell carcinoma. Int J Oncol. 45:710–718. 2014.PubMed/NCBI
11	Huang BS, Luo QZ, Han Y, Li XB, Cao LJ and Wu LX: microRNA-223 promotes the growth and invasion of glioblastoma cells by targeting tumor suppressor PAX6. Oncol Rep. 30:2263–2269. 2013.PubMed/NCBI
12	Chen KC, Hsieh IC, Hsi E, et al: Negative feedback regulation between microRNA let-7g and the oxLDL receptor LOX-1. J Cell Sci. 124:4115–4124. 2011. View Article : Google Scholar : PubMed/NCBI
13	Wang M, Li W, Chang GQ, et al: MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities. Arterioscler Thromb Vasc Biol. 31:2044–2053. 2011. View Article : Google Scholar : PubMed/NCBI
14	Goettsch C, Rauner M, Pacyna N, Hempel U, Bornstein SR and Hofbauer LC: miR-125b regulates calcification of vascular smooth muscle cells. Am J Pathol. 179:1594–1600. 2011. View Article : Google Scholar : PubMed/NCBI
15	Arocho A, Chen B, Ladanyi M and Pan Q: Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts. Diagn Mol Pathol. 15:56–61. 2006. View Article : Google Scholar : PubMed/NCBI
16	Sizemore S, Cicek M, Sizemore N, et al: Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin. Cancer Res. 67:6183–6191. 2007. View Article : Google Scholar : PubMed/NCBI
17	Wu H, Yang L, Liao D, Chen Y, Wang W and Fang J: Podocalyxin regulates astrocytoma cell invasion and survival against temozolomide. Exp Ther Med. 5:1025–1029. 2013.PubMed/NCBI
18	Sassetti C, Tangemann K, Singer MS, Kershaw DB and Rosen SD: Identification of podocalyxin-like protein as a high endothelial venule ligand for L-selectin: parallels to CD34. J Exp Med. 187:1965–1975. 1998. View Article : Google Scholar : PubMed/NCBI
19	Ghosh G, Subramanian IV, Adhikari N, et al: Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis. J Clin Invest. 120:4141–4154. 2010. View Article : Google Scholar : PubMed/NCBI
20	Kuhnert F and Kuo CJ: miR-17-92 angiogenesis micromanagement. Blood. 115:4631–4633. 2010. View Article : Google Scholar : PubMed/NCBI
21	Staszel T, Zapala B, Polus A, et al: Role of microRNAs in endothelial cell pathophysiology. Pol Arch Med Wewn. 121:361–366. 2011.PubMed/NCBI
22	Wu C, Gong Y, Yuan J, et al: microRNA-181a represses ox-LDL-stimulated inflammatory response in dendritic cell by targeting c-Fos. J Lipid Res. 53:2355–2363. 2012. View Article : Google Scholar : PubMed/NCBI
23	Li D and Mehta JL: Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation. 101:2889–2895. 2000. View Article : Google Scholar : PubMed/NCBI
24	Zhou M, Liu Z, Zhao Y, et al: MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem. 285:21496–21507. 2010. View Article : Google Scholar : PubMed/NCBI
25	Mizuno Y, Yagi K, Tokuzawa Y, et al: miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem Biophys Res Commun. 368:267–272. 2008. View Article : Google Scholar : PubMed/NCBI
26	Williams KJ and Tabas I: Atherosclerosis and inflammation. Science. 297:521–522. 2002. View Article : Google Scholar : PubMed/NCBI
27	Cushing SD, Berliner JA, Valente AJ, et al: Minimially modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA. 87:5134–5138. 1990. View Article : Google Scholar
28	Rose CE Jr, Sung SS and Fu SM: Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation. 10:273–288. 2003. View Article : Google Scholar : PubMed/NCBI
29	Villeneuve LM, Kato M, Reddy MA, Wang M, Lanting L and Natarjan R: Enchanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1. Diabetes. 59:2904–2915. 2010. View Article : Google Scholar : PubMed/NCBI
30	de Swiniarski R, Beatty D, Donoghue E, et al: Comparison of Schrodinger and Dirac coupled-channels analyses of the 28Si(p,p’)28Si reaction at 500 MeV. Phys Rev C Nucl Phys. 42:1137–1140. 1990. View Article : Google Scholar : PubMed/NCBI
31	Nigam V, Sievers HH, Jensen BC, et al: Altered microRNAs in bicuspid aortic valve: a comparison between stenotic and insufficient valves. J Heart Valve Dis. 19:459–465. 2010.PubMed/NCBI
32	Ji R, Cheng Y, Yue J, et al: MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res. 100:1579–1588. 2007. View Article : Google Scholar : PubMed/NCBI
33	Tili E, Michaille JJ, Cimino A, et al: Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-α stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol. 179:5082–5089. 2007. View Article : Google Scholar : PubMed/NCBI
34	Yu J, Li Y, Li M, Qu Z and Ruan Q: Oxidized low density lipoprotein-induced transdifferentiation of bone marrow-derived smooth muscle-like cells into foam-like cells in vitro. Int J Exp Pathol. 91:24–33. 2010. View Article : Google Scholar : PubMed/NCBI
35	Feng Y, Cai ZR, Tang Y, et al: TLR4/NF-κB signaling pathway-mediated and oxLDL-induced up-regulation of LOX-1, MCP-1, and VCAM-1 expressions in human umbilical vein endothelial cells. Genet Mol Res. 13:680–695. 2014. View Article : Google Scholar : PubMed/NCBI